Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.000
+1.3602.74%
Volume:37.24M
Turnover:1.87B
Market Cap:211.40B
PE:37.66
High:51.000
Open:49.500
Low:48.620
Close:49.640
52wk High:51.550
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.90
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.64%
ROA:6.88%
PB:3.83
PE(LYR):37.66
PS:8.32

Loading ...

Movement Alert|WuXi Biologics Rises 3.21% in Regular Trading, Aggressive Buyback Program and Sector Rebound Drive Recovery

Market Focus
·
Jun 12

WuXi Biologics makes S&P Global Sustainability Yearbook China edition for fourth straight year

Reuters
·
Jun 11

WUXI BIO issues 1.48 million new shares on option exercise and buys back 3.39 million shares under new mandate

Bulletin Express
·
Jun 11

WUXI BIO Executes Share Buyback, Spending Nearly HK$100 Million on June 11th

Stock News
·
Jun 11

Movement Alert|WuXi Biologics Falls 4.21% in Regular Trading, Continued Pressure from US Regulatory Actions Against WuXi Group

Market Focus
·
Jun 10

WUXI BIO completes HK$74.88 million share buyback, lifting pending cancellations to 21.10 million shares

Bulletin Express
·
Jun 09

WUXI BIO Executes Share Buyback, Spending HK$74.9 Million on June 9

Stock News
·
Jun 09

WuXi Biologics files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 09

WUXI BIO Grants 288,400 Restricted Shares

Stock News
·
Jun 09

Wuxi Biologics (Cayman) Stock Sheds 1.4% in Hong Kong

Dow Jones
·
Jun 09

Movement Alert|WuXi Biologics Falls 3.09% in Regular Trading, CXO Sector Extends Multi-Day Selloff Amid US Biosecurity Legislation Concerns

Market Focus
·
Jun 09

Key Corporate Developments and Share Repurchases Highlight Hong Kong Market Activity

Stock News
·
Jun 09

WUXI BIO Executes HK$200 Million Share Repurchase on June 8

Stock News
·
Jun 08

Wuxi Biologics (Cayman) Stock Slides 7.2% in Hong Kong

Dow Jones
·
Jun 08

Assessing WuXi Biologics (SEHK:2269) Valuation After Its Recent Share Price Momentum Shift

Simply Wall St.
·
Jun 07

Is WuXi Biologics (SEHK:2269) Offering Value After Its Recent Share Price Recovery?

Simply Wall St.
·
Jun 06

WUXI BIO Executes Major Share Buyback, Spending Nearly HK$100 Million

Stock News
·
Jun 05

WuXi Biologics tops out Singapore modular drug product facility, targets 100 million units annual output

Reuters
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

Movement Alert|WuXi Biologics Rises 3.7% in Regular Trading, USD 400 Million Buyback Ongoing as CICC Maintains HKD 48 Target Price

Market Focus
·
Jun 05